Sensitivity and Specificity of Treponemal-specific Tests for the Diagnosis of Syphilis
Clinical Infectious Diseases·
- DOI
- 10.1093/cid/ciaa349
- PMID
- 32578866
- PMCID
- PMC7312216
- OpenAlex
- W3037103756
- Study type
- Systematic review
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Clarifying the operational characteristics of validated screening tools assists health authorities in maintaining consistent diagnostic pathways and optimizing laboratory resource distribution for endemic disease control.
Structured evidence summary
Research question
The investigation seeks to determine the diagnostic accuracy of United States Food and Drug Administration-approved treponemal assays across distinct clinical stages of syphilis.
Study design
This work employs a systematic review framework to synthesize existing literature on laboratory test performance metrics.
Population and setting
The analysis encompasses cohorts presenting with early-stage infections as well as individuals undergoing evaluation for neurological involvement via cerebrospinal fluid sampling.
Main findings
Manual techniques such as MHA-TP and FTA-ABS exhibited reduced sensitivity during initial infection phases relative to TP-PA, which also maintained the highest specificity among manual options. Comparative data failed to demonstrate definitive advantages for any specific automated immunoassay platform. Cerebrospinal fluid applications revealed equivalent accuracy between TP-PA and FTA-ABS but carry recognized analytical constraints that mandate integration with broader clinical indicators.
Public-health relevance
Clarifying the operational characteristics of validated screening tools assists health authorities in maintaining consistent diagnostic pathways and optimizing laboratory resource distribution for endemic disease control.
Important limitations
This assessment is restricted to the provided abstract and metadata, requiring examination of the full manuscript for decision-grade interpretation.
GIDS interpretation
The record supplies benchmark performance parameters that contextualize current diagnostic standards within laboratory medicine literature. Its cataloging supports ongoing tracking of test validation trends without suggesting alignment with real-time epidemiological monitoring networks.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 8 auditable classifier relationships to diseases, places, topics, and study design.